Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres.
Mullard, A Misra, Vivek Sumra, Priya Ali, Z O'Reilly, S Malik, Z
Mullard, A
Misra, Vivek
Sumra, Priya
Ali, Z
O'Reilly, S
Malik, Z
Citations
Altmetric:
Abstract
Primary prophylaxis with granulocyte colony-stimulating factor (G-CSF) is used in many institutions across the UK due to unacceptable febrile neutropenia (FN) rates with FEC-D (fluorouracil, epirubicin, cyclophosphamide-docetaxel). The resultant reduction in FN rate is thought to maintain dose intensity and improve patient experience. This retrospective study was performed to assess whether the addition of G-CSF primary prophylaxis into daily clinical practice has achieved these aims.
Description
Date
2014-08
Publisher
Collections
Keywords
Type
Article
Citation
Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. 2014, 22 (8):2033-7 Support Care Cancer